CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,966,069
- in 2 filings, $18.0M under 10b5-1 plans
Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-29 | Krishnan Krish S President and CEO | Sale | −528 | $81.10 | $43K | 1,707,901 |
| 2022-12-16 | Krishnan Suma President, R&D | Sale | −10,527 | $80.10 | $843K | 1,715,913 |
| 2022-12-16 | Krishnan Suma President, R&D | Sale | −10,572 | $80.10 | $847K | 1,777,146 |
| 2022-12-16 | Krishnan Krish S President and CEO | Sale | −10,572 | $80.10 | $847K | 1,777,146 |
| 2022-12-16 | Krishnan Krish S President and CEO | Sale | −10,527 | $80.10 | $843K | 1,715,913 |
| 2022-11-23 | Krishnan Suma President, R&D | Sale | −4 | $80.01 | $320 | 1,787,718 |
| 2022-11-23 | Krishnan Krish S President and CEO | Sale | −4 | $80.01 | $320 | 1,787,718 |
| 2022-11-08 | Krishnan Suma President, R&D | Sale | −823 | $80.04 | $66K | 1,726,440 |
| 2022-11-08 | Krishnan Suma President, R&D | Sale | −966 | $80.05 | $77K | 1,787,722 |
Page 35 of 35 · 689 trades